Alpa Laboratories Ltd (ALPA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 532878 | NSE: ALPA | Pharmaceuticals & Drugs | Small Cap

Alpa Lab Share Price

46.25 -5.32 -10.32%
as on 30-Mar'26 16:59

DeciZen - make an informed investing decision on Alpa Lab

Based on:

M-Cap below 100cr DeciZen not available

Alpa Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
8.24
Market Cap:
97.3 Cr.
52-wk low:
46
52-wk high:
118.8

Is Alpa Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Alpa Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alpa Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.3%9.5%7%4.8%4.8%9.5%15.5%11.3%13.4%15%-
Value Creation
Index
-0.3-0.3-0.5-0.7-0.7-0.30.1-0.20.00.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 53.563.462.3788697.611293109112114
Sales YoY Gr.-18.5%-1.8%25.2%10.2%13.5%15.1%-17.2%17%3.4%-
Adj EPS 3.53.32.212.32.63.74.27.79.15.6
YoY Gr.--5.7%-33.1%-55.9%135.7%10.8%43.8%15.2%82.3%17.5%-
BVPS (₹) 44.846.849.150.452.455.962.6697786.492.9
Adj Net
Profit
7.474.72.14.95.47.78.916.319.112
Cash Flow from Ops. -24.8-8.1-7.3-0.717.7-1.52.210.23.718.4-
Debt/CF from Ops. -1-1.3-0.8-2.50-0.12.70.31.40-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.6%5.5%0.1%3.4%
Adj EPS 11.1%31.5%35.1%17.5%
BVPS7.6%10.5%11.4%12.3%
Share Price 1.9% 5.1% -4.9% -55.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
8.27.34.624.54.76.26.510.611.16.3
Op. Profit
Mgn %
11.711.26.71.66.98.99.58.77.54.5-0.6
Net Profit
Mgn %
13.9117.52.75.75.56.99.6151710.4
Debt to
Equity
0.30.10.10000000-
Working Cap
Days
403432356280238222224279241246290
Cash Conv.
Cycle
1461471481261068297154141140220

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Alpa Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 5.6 5.5
TTM Sales (₹ Cr.) 114 114
BVPS (₹.) 92.9 88
Reserves (₹ Cr.) 175 164
P/BV 0.50 0.53
PE 8.24 8.35
From the Market
52 Week Low / High (₹) 46.00 / 118.80
All Time Low / High (₹) 5.50 / 144.60
Market Cap (₹ Cr.) 97.3
Equity (₹ Cr.) 21
Face Value (₹) 10
Industry PE 40.8

Management X-Ray of Alpa Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Alpa Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Alpa Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales53.5063.3862.2777.9985.9797.55112.2792.96108.74112.45
Operating Expenses 47.2656.2858.3276.7782.5289.85101.5884.88100.59107.45
Manufacturing Costs2.843.303.574.264.275.296.316.556.575.85
Material Costs27.8836.3235.6748.8350.9959.4769.7854.9468.0470.20
Employee Cost 7.178.6210.2612.0411.8211.7511.9312.1713.2614.37
Other Costs 9.368.048.8111.6415.4313.3513.5611.2112.7317.04
Operating Profit 6.247.103.951.223.457.7110.698.088.145
Operating Profit Margin (%) 11.7%11.2%6.3%1.6%4.0%7.9%9.5%8.7%7.5%4.5%
Other Income 6.666.594.725.072.974.4110.799.4114.8723.31
Interest 1.451.711.070.570.200.100.240.220.390.27
Depreciation 0.830.761.051.101.141.231.661.331.952.20
Exceptional Items 0-2.1200000000
Profit Before Tax 10.639.106.554.625.0810.7919.5815.9320.6725.84
Tax 2.893.121.781.6713.535.453.313.906.16
Profit After Tax 7.745.994.772.954.087.2614.1312.6216.7819.68
PAT Margin (%) 14.5%9.4%7.7%3.8%4.7%7.4%12.6%13.6%15.4%17.5%
Adjusted EPS (₹)3.72.92.31.41.93.56.76.08.09.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 94.3098.46103.24106.13110.23117.52131.64145.11161.97181.80
Share Capital 21.0421.0421.0421.0421.0421.0421.0421.0421.0421.04
Reserves 73.2677.4282.2085.0989.1996.48110.60124.07140.93160.76
Minority Interest0000000000
Debt24.2310.635.791.460.190.014.471.074.460.03
Long Term Debt00.470.610.410.190.012.120.7800
Short Term Debt24.2310.165.181.05002.340.294.460.03
Trade Payables18.6213.9312.7013.1813.6924.7214.8915.0511.7718.68
Others Liabilities 9.955.404.097.886.167.9914.1416.8614.2332.46
Total Liabilities 147.10128.42125.83128.65130.28150.23165.14178.09192.42232.98

Fixed Assets

Gross Block24.6226.0428.0128.7530.0130.6434.4133.4639.8451.22
Accumulated Depreciation20.1020.8621.8922.9923.6023.4325.0926.4228.3730.57
Net Fixed Assets 4.535.186.125.766.427.219.327.0411.4720.65
CWIP 0000.120.811.570000
Investments 22.1323.4941.3459.4367.6161.9385.7388.85109.27129.26
Inventories1513.0413.7214.0412.5516.5615.4612.6413.6717.64
Trade Receivables34.2629.1625.4429.8124.5935.4338.0447.3741.1546.83
Cash Equivalents 34.7635.5321.290.885.9210.241.318.741.261.68
Others Assets 36.4222.0217.9118.6112.3917.3015.2813.4415.6016.92
Total Assets 147.10128.42125.83128.65130.28150.23165.14178.09192.42232.98

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -24.78-8.14-7.29-0.6817.66-1.472.2010.203.7018.39
PBT 10.639.106.554.625.0810.7919.5815.7220.7625.99
Adjustment -1.12-2.79-1.09-1.073.700.71-7.95-1.47-9.86-15.78
Changes in Working Capital -31.39-11.34-10.97-2.149.99-10.11-5.85-0.46-3.5712.25
Tax Paid -2.89-3.11-1.78-2.09-1.10-2.87-3.57-3.60-3.63-4.07
Cash Flow From Investing Activity -6.971.09-15.78-14.95-11.275.82-15.611.17-12.45-12.49
Capex -0.49-1.42-1.97-0.85-2.55-2.84-2.19-1.13-6.39-11.38
Net Investments -12.03-3.11-17.98-11.87-11.617.91-14.94-0.46-8.51-3.39
Others 5.555.624.17-2.222.880.751.522.762.452.28
Cash Flow From Financing Activity -5.62-2.364.42-4.78-1.35-0.035.41-3.482.26-5.48
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00.470.15-0.20-0.22-0.182.120.18-0.780
Interest Paid -1.28-1.71-1.07-0.57-0.20-0.10-0.24-0.22-0.39-0.27
Dividend Paid 0000000000
Others -4.34-1.125.33-4-0.930.253.54-3.433.43-5.21
Net Cash Flow -37.37-9.41-18.65-20.405.034.32-7.997.89-6.490.43

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)8.566.214.722.823.776.3811.349.1210.9311.45
ROCE (%)10.349.56.984.784.839.5415.5411.3313.3814.96
Asset Turnover Ratio0.420.460.490.610.660.70.710.540.590.53
PAT to CFO Conversion(x)-3.2-1.36-1.53-0.234.33-0.20.160.810.220.93
Working Capital Days
Receivable Days187183160129115112119168149143
Inventory Days72817865565452554451
Payable Days1811641369796118104997279

Alpa Laboratories Ltd Stock News

Alpa Laboratories Ltd FAQs

The current trading price of Alpa Lab on 30-Mar-2026 16:59 is ₹46.25.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Mar-2026 the market cap of Alpa Lab stood at ₹97.31.
The latest P/E ratio of Alpa Lab as of 29-Mar-2026 is 8.24.
The latest P/B ratio of Alpa Lab as of 29-Mar-2026 is 0.50.
The 52-week high of Alpa Lab is ₹118.8 and the 52-week low is ₹46.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alpa Lab is ₹114 ( Cr.) .

About Alpa Laboratories Ltd

Incorporated as Alpa Laboratories Private Limited on March 18, 1988 under the Companies Act, 1956 and converted to public limited company on September 3, 1998 with the name of Alpa Laboratories Limited. The company has been listed on the Bombay Stock Exchange and the National Stock Exchange since August 6, 2007.

Alpa Laboratories Limited is a WHO-GMP and ISO 9001:2000 certified company located at Pigdamber, about 15 kilometers from the city of Indore in Central India. The company has been manufacturing Pharmaceutical Finished Dosage Forms since 1967. With its focus on quality, the company has earned tremendous faith and confidence of its associates.

The manufacturing facility is less than 20 kilometers from the center of the city of Indore in Central India and is spread over 1.20 acres. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. The production areas are designed to maximize output quality and quantity with minimal down time.

The facility is WHO-GMP certified and all manufacturing areas are supplied with independent air supply systems for individual department. The independent supply systems are fed with separate air handling units to avoid cross contamination. Pressure gradients are maintained and monitored and the required air quality of class 100, 1000, 10,000 and class 100,000 is maintained.

Business area of the company

The company manufactures a wide range of products under its own brand and for a number of other reputed Indian and multinational companies. The product range includes a wide variety of ethical, generic and over the counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use.

Products

Capsules: Equipment used for the production of hard-gelatin capsules are automatic filling machine, feeder, sorter, inspection machine and polishing machine. The filled capsules are packed in high speed automatic strip and blister packing machines suitable for various sizes. The company has the ability to produce both powder filled and granule filled capsules.

Creams, Gels & Ointments: The semi-automatic machines perform the entire process of filling, sealing & crimping of the tubes in various tube sizes of Creams, Gels, Ointments, Sterile Ophthalmic Ointments and Sterile intra-mammary infusions.

Ear & Eye Drops: This department houses sophisticated machines such as automatic sealing, capping, labeling, carton forming and wrapping machines.

Injections: The parenteral is produced in a sterile area and fed to the automatic machines for ampule or vial filling, rubber bunging and cap sealing. A similar process is used for dry powder injections.

Tablets: Rapid Mixer Granulator and Fluid Bed Dryer are used to produce the material for compression in various shapes which is carried out at various multi-station, single and double rotary tablet compression machines. There are coating machines for various types of coating of the tablets. A similar process is used for boluses.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×